Pharmacological targeting of VEGFR signaling with axitinib inhibits <i>Tsc2</i>-null lesion growth in the mouse model of lymphangioleiomyomatosis
Elena N. Atochina‐Vasserman(University of Pennsylvania), Vera P. Krymskaya(Lung Institute)
American Journal of Physiology-Lung Cellular and Molecular Physiology
October 2, 2015
Cited by 31
Related Papers
Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation
|Journal of Biological Chemistry|2002|430
Signal Transducer and Activator of Transcription 3 Is Required for Abnormal Proliferation and Survival of TSC2-Deficient Cells: Relevance to Pulmonary Lymphangioleiomyomatosis
|Molecular Pharmacology|2009|41
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis
|American Journal of Respiratory Cell and Molecular Biology|2024|6